OK, that's oversimplifying the job quite a bit. But twisting up “standardized marijuana cigarettes” with strains of various potencies will be one of the responsibilities of whatever small business lands a contract with NIDA, posted Oct. 24, 2018, to prepare and distribute research drug products.
If your business is capable of analyzing cannabinoids and research chemicals, creating “drug dosage forms” for compounds such as THC and producing marijuana and nicotine research cigarettes “of varying strengths and specifications,” this could be the gig for you. Applicants must also obtain licenses to manufacture, research, distribute and export and import Schedule I and II drugs before the time of the contract award, which is estimated to be July 2019.
Here's the full description of the job responsibilities:
- Acquire hard-to-find controlled and uncontrolled drug compounds and/or drug dosage forms and analyze purity, authenticity, and stability of these compounds while storing them in a secure, DEA-approved facility and having the capability to ship these compounds to research investigators.
- Manufacture standardized marijuana cigarettes within a range of varying concentrations of delta-9-THC and analyze strength and stability of them at various intervals while having the capability to maintain a secure shipping facility and to ship marijuana cigarettes to research investigators.
- Manufacture nicotine research cigarettes and analyze them for required chemical constituents at various intervals while having the capability to store and ship securely these nicotine research cigarettes to research investigators.
The successful applicant must be able to demonstrate “extensive experience with and the ability to perform the above tasks,” NIDA's notice says.
There's no information available in the federal posting about how much the contract award is worth — but the pay is presumably higher than what rapper Waka Flocka Flame offered for a full-time blunt roller position in 2015.
This article has been republished from Marijuana Moment under a content syndication agreement. Read the original article here.